$107.78 -0.21 (%) Gilead Sciences Inc - NASDAQ

Aug. 28, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's M&A Chatter for Thursday August 27, 2015

    Benzinga | Aug. 27, 2015 | 19:15PM EST
  2. 12 Attractive Fast-Growing Dividend Growth Stocks for High Total Return

    GuruFocus | Aug. 27, 2015 | 15:53PM EST
  3. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    Benzinga | Aug. 27, 2015 | 11:06AM EST
  4. Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Arterial Hypertension Published in The New England Journal of Medicine

    Benzinga | Aug. 26, 2015 | 17:01PM EST
  5. The Other Bearish Biotech ETF Is Looking Groovy, Too

    Benzinga | Aug. 21, 2015 | 15:24PM EST
  6. Dividend Investors Should Consider Johnson & Johnson

    GuruFocus | Aug. 19, 2015 | 18:36PM EST
  7. JNJ - Should It Be In Your Portfolio?

    GuruFocus | Aug. 19, 2015 | 12:13PM EST
  8. Weekly CFO Sells Highlight: Facebook, Public Storage, Gilead Sciences

    GuruFocus | Aug. 17, 2015 | 12:48PM EST
  9. John Buckingham Buys 10 New Stakes in Second Quarter

    GuruFocus | Aug. 14, 2015 | 19:08PM EST
  10. Ronald Muhlenkamp Makes Small Changes in Composition of His Top 10 Stakes

    GuruFocus | Aug. 6, 2015 | 16:37PM EST
  11. These Two Biotechs Boast Big EPS Growth Rates

    IBD | Aug. 6, 2015 | 11:14AM EST
  12. What Company Will Be Fastest Growing Big-Cap Biotech?

    IBD | Aug. 5, 2015 | 14:58PM EST
  13. Big Cap Leaders Sail Past Earnings Season

    IBD | Aug. 3, 2015 | 18:48PM EST
  14. Stocks Slump In Afternoon Trade; Fitbit Soars

    IBD | Aug. 3, 2015 | 13:34PM EST
  15. A Look Ahead: Consumer Discretionary And Greek ETFs To Watch This Week

    Benzinga | Aug. 2, 2015 | 10:30AM EST
  16. 1% Q2 Profit Growth Is S&P 500's Weakest Since '12

    IBD | Jul. 31, 2015 | 08:02AM EST
  17. Even With Recent Declines, Investors Still Love Biotech ETFs

    Benzinga | Jul. 30, 2015 | 14:52PM EST
  18. Apple, Gilead and Hibbett Display Both Growth and Value

    GuruFocus | Jul. 29, 2015 | 16:35PM EST
  19. Gilead Gets Wall Street Love After Q2 Earnings Beat

    IBD | Jul. 29, 2015 | 12:29PM EST
  20. Morning Market Gainers

    Benzinga | Jul. 29, 2015 | 09:46AM EST
  21. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 29, 2015 | 08:14AM EST
  22. Fast Money Picks For July 29

    Benzinga | Jul. 29, 2015 | 06:44AM EST
  23. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD | Jul. 28, 2015 | 20:07PM EST
  24. Gilead Beats, Lifts Outlook

    IBD | Jul. 28, 2015 | 18:37PM EST
  25. Stocks Post First Gain In 6 Days; Twitter, Gilead Leap On Earnings

    IBD | Jul. 28, 2015 | 16:57PM EST
  26. Tuesday's After-Hours Movers: Twitter, Gilead, Yelp And Buffalo Wild Wings

    Benzinga | Jul. 28, 2015 | 16:53PM EST
  27. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 16:34PM EST
  28. Gilead Sciences Q2 Profit Beats Views, Shares Rise

    Benzinga | Jul. 28, 2015 | 16:31PM EST
  29. Options Strategist Discusses Activity In Gilead And Wynn Ahead Of Earnings

    Benzinga | Jul. 28, 2015 | 15:50PM EST
  30. Stocks Push Ahead In Late Trade; Jazz Clears Buy Point

    IBD | Jul. 28, 2015 | 15:05PM EST
  31. Which Big-Cap Stocks Are Defying Market Pressure?

    IBD | Jul. 27, 2015 | 18:46PM EST
  32. A Big Day For Biotech And It's Not Going So Well

    Benzinga | Jul. 27, 2015 | 13:10PM EST
  33. Meet 5 IBD 50 Stocks Reporting Earnings This Week

    IBD | Jul. 25, 2015 | 10:02AM EST
  34. Gilead Sciences Leads 3 Top-Rated Big Cap Stocks

    IBD | Jul. 22, 2015 | 08:02AM EST
  35. Gilead's Fantastic Growth Expected To Slow

    IBD | Jul. 17, 2015 | 18:48PM EST
  36. It's Not Too Late To Buy Gilead Sciences

    GuruFocus | Jul. 17, 2015 | 12:01PM EST
  37. Why Big Biotech Could Have Another Leg Up

    Benzinga | Jul. 17, 2015 | 10:49AM EST
  38. Which Top Biotechs Still In Play After Celgene Rally?

    IBD | Jul. 16, 2015 | 18:45PM EST
  39. Fitbit Leads Trio Of Hot Health-Related IPO Stocks

    IBD | Jul. 15, 2015 | 17:50PM EST
  40. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  41. Celgene Hits High As Street Applauds Receptos Buyout

    IBD | Jul. 15, 2015 | 11:12AM EST
  42. Johnson & Johnson Profit Dips

    IBD | Jul. 14, 2015 | 18:54PM EST
  43. Stocks Hold On To Most Gains; Biotechs Quicken Their Pulse

    IBD | Jul. 14, 2015 | 13:19PM EST
  44. J&J Earnings Beat Views As Pharma Leads Way Again

    IBD | Jul. 14, 2015 | 11:18AM EST
  45. Fast Money Picks For July 14

    Benzinga | Jul. 14, 2015 | 06:40AM EST
  46. Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant

    IBD | Jul. 13, 2015 | 18:43PM EST
  47. Don't Count Out Top Biotechs — They Still Got Game

    IBD | Jul. 10, 2015 | 18:05PM EST
  48. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 06:52AM EST
  49. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD | Jul. 9, 2015 | 11:12AM EST
  50. Apple: A Top Fidelity Manager Sticks By The Stock

    IBD | Jul. 7, 2015 | 18:53PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!